Showing 81-90 of 915 results for "".
TELEMEDICINE AND ONLINE PRESENCE
https://practicaldermatology.com/topics/practice-management/matv-sacopulos-2--ahooremm/19114/Is telemedicine the next wave of medical practice? Michael J. Sacopulos, JD (www.medriskinstitute.com) weighs in.Interoperability Redux
https://practicaldermatology.com/topics/practice-management/interoperability-redux/20455/Is the new push for interoperability déjà vu all over again?Updates on Psoriasis Biologics
https://practicaldermatology.com/programs/practical-dermatology/updates-on-psoriasis-biologics/35894/Jashin J. Wu, MD, discusses biologics for psoriasis, including a meta-analyses of best biologics for different types of the condition, at Music City SCALE 2025.Patient Portals
https://practicaldermatology.com/topics/practice-management/patient-portals/19113/Michael J. Sacopulos, JD, Founder and President of Medical Risk Institute (www.medriskinstitute.com), addresses the role, benefits, and potential pitfalls of patient portals.New Allergens Causing Contact Dermatitis
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/new-allergens-causing-contact-dermatitis/54644/Walter J. Liszewski, MD, discusses key takeaways from the “Contact Dermatitis Update 2026” session at Maui Derm Hawaii 2026.GEP Testing in Surgical Oncology
https://practicaldermatology.com/videos/updates-in-skin-cancer/gep-testing-in-surgical-oncology/35601/Surgical oncologist J. Michael Guenther, MD, discusses how to use gene expression profile (GEP) testing for managing melanoma patients.The Risk of Violence Against Physicians
https://practicaldermatology.com/topics/practice-management/the-risk-of-violence-against-physicians/19641/Violence against healthcare workers is a real and growing risk. Kathleen J. Hectorne, MD outlines the problem and ways to de-escalate an encounter.Evolving Atopic Dermatitis Therapeutic Capabilities
https://practicaldermatology.com/videos/c-suite-chats/evolving-atopic-dermatitis-therapeutic-capabilities/67100/J. Mark Jackson, MD, FAAD, Senior Vice President, Clinical Development for Evommune, discusses the importance of improved efficacy and safety for underserved patients with atopic dermatitis.@PRACTICAL_DERM
https://practicaldermatology.com/topics/skin-cancer-photoprotection/practical_derm/21185/Disease Deep Dive: The Evolving Role of Nonsteroidal Topical Therapy for Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/deep-dive-the-evolving-role-of-nonsteroidal-topical-therapy-for-atopic-dermatitis/57279/Walter J. Liszewski, MD, and Adelaide A. Hebert, MD, discuss nonsteroidal approaches to atopic dermatitis, including treatment simplification, pediatric use, remittive potential, quality-of-life considerations, and practical prescribing strategies.